| Literature DB >> 26295149 |
Zhu Zhuo1, Susan J Lamont2, William R Lee3, Behnam Abasht1.
Abstract
For economic and environmental reasons, chickens with superior feed efficiency (FE) are preferred in the broiler chicken industry. High FE (HFE) chickens typically have reduced abdominal fat, the major adipose tissue in chickens. In addition to its function of energy storage, adipose tissue is a metabolically active organ that also possesses endocrine and immune regulatory functions. It plays a central role in maintaining energy homeostasis. Comprehensive understanding of the gene expression in the adipose tissue and the biological basis of FE are of significance to optimize selection and breeding strategies. Through gene expression profiling of abdominal fat from high and low FE (LFE) commercial broiler chickens, the present study aimed to characterize the differences of gene expression between HFE and LFE chickens. mRNA-seq analysis was carried out on the total RNA of abdominal fat from 10 HFE and 12 LFE commercial broiler chickens, and 1.48 billion of 75-base sequence reads were generated in total. On average, 11,565 genes were expressed (>5 reads/gene/sample) in the abdominal fat tissue, of which 286 genes were differentially expressed (DE) at q (False Discover Rate) < 0.05 and fold change > 1.3 between HFE and LFE chickens. Expression levels from RNA-seq were confirmed with the NanoString nCounter analysis system. Functional analysis showed that the DE genes were significantly (p < 0.01) enriched in lipid metabolism, coagulation, and immune regulation pathways. Specifically, the LFE chickens had higher expression of lipid synthesis genes and lower expression of triglyceride hydrolysis and cholesterol transport genes. In conclusion, our study reveals the overall differences of gene expression in the abdominal fat from HFE and LFE chickens, and the results suggest that the divergent expression of lipid metabolism genes represents the major differences.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26295149 PMCID: PMC4546421 DOI: 10.1371/journal.pone.0135810
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Phenotypic data of samples used in RNA-seq (Mean ± S.E.)
| BW46 (kg) | FC (kg) | WG (kg) | Breast muscle percentage (%BW) | Fat percentage (%BW) | FCR | RFC (kg) | |
|---|---|---|---|---|---|---|---|
| HFE | 3.12±0.07 | 2.91±0.05 | 1.81±0.04 | 23.46±0.48 | 1.52±0.15 | 1.61±0.02 | -0.28±0.01 |
| LFE | 3.03±0.06 | 3.34±0.05 | 1.62±0.04 | 21.75±0.44 | 2.36±0.13 | 2.07±0.02 | 0.36±0.01 |
* Indicates significant difference (t-test, p<0.01) between HFE and LFE groups. Calculations of FCR and RFC are described in Methods and Materials. Abbreviations: BW46: body weight at Day 46; FC: Feed consumption; WG: Weight gain; FCR: Feed conversion ration; RFC: Residual fee consumption.
Fig 1Summary of RNA-Seq data.
a. Average mapping statistics. b. Hierarchical clustering of samples based on gene expression profile.
Top 10 up- and down-regulated genes in LFE group.
| Ensembl gene ID |
| Fold Change |
|---|---|---|
| Up-regulated genes | FPKMLFE / FPKMHFE | |
| ENSGALG00000009118 |
|
|
| ENSGALG00000009266 |
|
|
| ENSGALG00000008601 |
|
|
| ENSGALG00000003957 |
|
|
| ENSGALG00000020180 |
|
|
| ENSGALG00000019845 |
|
|
| ENSGALG00000008973 |
|
|
| ENSGALG00000011612 |
|
|
| ENSGALG00000009262 |
|
|
| ENSGALG00000016667 |
|
|
| Down-regulated genes | FPKMHFE / FPKMLFE | |
| ENSGALG00000002614 |
|
|
| ENSGALG00000012670 |
|
|
| ENSGALG00000023622 |
|
|
| ENSGALG00000016364 |
|
|
| ENSGALG00000003212 |
|
|
| ENSGALG00000019325 |
|
|
| ENSGALG00000029151 |
|
|
| ENSGALG00000026075 |
|
|
| ENSGALG00000001417 |
|
|
| ENSGALG00000015166 |
|
|
↑ indicates up-regulation in LFE group
↓ indicates down-regulation in LFE group
Top networks from IPA results.
| ID | Associated Network Functions | Score |
|---|---|---|
| 1 | Developmental Disorder, Hematological Disease, Hereditary Disorder | 40 |
| 2 | Cardiovascular System Development and Function, Organismal Development, Cell-to-Cell Signaling and Interaction | 35 |
| 3 | Drug Metabolism, Lipid Metabolism, Molecular Transport | 33 |
| 4 | Organismal Injury and Abnormalities, Tissue Morphology, Reproductive System Development and Function | 28 |
| 5 | Cellular Movement, Immune Cell Trafficking, Inflammatory Response | 27 |
1Scores were calculated by IPA to rank the relevancy of DE genes and networks.
Top molecular and cellular functions.
| Name | p-value | # molecule |
|---|---|---|
| Lipid Metabolism | 2.31E-07–6.53E-03 | 30 |
| Molecular Transport | 2.31E-07–6.53E-03 | 31 |
| Small Molecule Biochemistry | 2.31E-07–7.46E-03 | 34 |
| Vitamin and Mineral Metabolism | 3.37E-06–5.54E-03 | 12 |
| Cellular Movement | 4.52E-06–7.17E-03 | 31 |
1p-values were calculated with a Fisher-extract test contingency table by IPA.
2# molecule indicates the number of DE genes involved in the molecular and cellular function
Top 10 canonical pathways.
| Ingenuity canonical pathways | p-value | Ratio |
|---|---|---|
| LXR/RXR activation | 1.00E-10 | 1.01E-01 |
| Acute phase response signaling | 5.25E-07 | 6.63E-02 |
| Cholesterol biosynthesis i | 1.07E-05 | 1.00E-01 |
| Cholesterol biosynthesis ii (via 24,25-dihydrolanosterol) | 1.07E-05 | 1.00E-01 |
| Cholesterol biosynthesis iii (via desmosterol) | 1.07E-05 | 1.00E-01 |
| Superpathway of cholesterol biosynthesis | 2.04E-05 | 5.75E-02 |
| Extrinsic prothrombin activation pathway | 2.63E-05 | 1.82E-01 |
| Zymosterol biosynthesis | 2.82E-05 | 1.36E-01 |
| Intrinsic prothrombin activation pathway | 2.63E-04 | 1.08E-01 |
| Oleate biosynthesis ii (animals) | 2.95E-04 | 1.67E-01 |
1p-values were calculated with a Fisher-extract test contingency table by IPA.
2Ratio = number of DE genes mapped to the pathway/total number of genes of the pathway.
Fig 2The DE genes involved in accumulation of lipid and upstream regulator INSIG1.
a. The accumulation of lipid is predicted to be activated in LFE group. b. Upstream regulator INSIG1. Cholesterol biosynthesis regulator INSIG1 is predicted to be inhibited in LFE chickens.
Fig 3Correlations of log2 fold-change between RNA-seq FPKM and Nanostring gene count.
Summary of DE genes involved in lipid accumulation.
| Functional category | Gene Name | Full Name | RNA-Seq fold change |
|---|---|---|---|
| Fatty acid transportation |
|
|
|
| Stabilization of fatty acid |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
| Triglyceride hydrolysis |
|
|
|
| Cholesterol synthesis |
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
| Cholesterol transport |
|
|
|
|
|
|
| |
| Steroidogenesis |
|
|
|
|
|
|
| |
| Adipogenesis |
|
|
|
|
|
|
| |
|
|
|
|
↑ indicates up-regulation in LFE group, fold change = FPKMLFE / FPKMHFE
↓ indicates down-regulation in LFE group, fold change = FPKMHFE / FPKMLFE